Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF): a randomised, open-label, phase 2 trial - The Lancet Neurology
Safety and effectiveness of reduced-dose apixaban in Japanese patients with nonvalvular atrial fibrillation in clinical practice: A sub-analysis of the STANDARD study - Journal of Cardiology
A Prospective Randomized Trial of Apixaban Dosing During Atrial Fibrillation Ablation: The AEIOU Trial | JACC: Clinical Electrophysiology
Rates of Potentially Inappropriate Dosing of Direct‐Acting Oral Anticoagulants and Associations With Geriatric Conditions Among Older Patients With Atrial Fibrillation: The SAGE‐AF Study | Journal of the American Heart Association
Apixaban (BMS 562247-01) | ≥99%(HPLC) | Selleck | Factor Xa inhibitor
Apixaban for Reduction In Stroke and Other ThromboemboLic Events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationale - ScienceDirect
Frontiers | Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma Receiving Immunomodulatory Therapy
About ELIQUIS™ | 凝血通™(ELIQUIS™) HK
Secondary stroke prevention with apixaban in nonvalvular atrial fibrillation: A subgroup analysis of the STANDARD study - Journal of Stroke and Cerebrovascular Diseases
Primary Care Initiation of Direct Oral Anticoagulants (DOACs) for Stroke Prevention in Atrial Fibrillation (AF) – GP Gateway
Apixaban and rivaroxaban anti-Xa level utilization and associated bleeding events within an academic health system - Thrombosis Research
Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial - The Lancet
Apixaban - Uses | Dosage | Side Effects | Drug Warnings | and Precautions
Apixaban 5 and 2.5 mg twice-daily versus warfarin for stroke prevention in nonvalvular atrial fibrillation patients: Comparative effectiveness and safety evaluated using a propensity-score-matched approach | PLOS ONE
Personalized Anticoagulation: Guided Apixaban Dose Adjustment to Compensate for Pharmacokinetic Abnormalities Related to Short-Bowel Syndrome - Canadian Journal of Cardiology
Update on EP Mobile and Apple – EP Studios
How Much Does Eliquis Cost with Medicare? Is it covered?
Direct Oral Anticoagulants (DOACs) - UKCPA
Savings Calculator: Save on Rebate Management | Health Delegates
CHADS 2 index to calculate stroke risk in patients with nonvalvular... | Download Table
O-Demethyl apixaban sulfate | CAS# 1118765-14-2 | Xa Inhibitor Metabolite | MedKoo
Antithrombotic Therapy for Atrial Fibrillation - CHEST
Bleeding Risk Following Systemic Fluconazole or Topical Azoles in Patients with Atrial Fibrillation on Apixaban, Rivaroxaban, or Dabigatran - The American Journal of Medicine
The Problem With Predictions: A Cautionary Tale of Empirically Adjusting Apixaban Dosing With Carbamazepine - ScienceDirect
